ProShare Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,666
| Closed | -$123K | – | 2133 |
|
|
2025
Q1 | $123K | Sell |
10,666
-1,240
| -10% | -$14.3K | ﹤0.01% | 1793 |
|
|
2024
Q4 | $101K | Buy |
+11,906
| New | +$101K | ﹤0.01% | 2073 |
|
|
2021
Q3 | – | Sell |
-9,546
| Closed | -$229K | – | 2130 |
|
|
2021
Q2 | $229K | Buy |
9,546
+1,228
| +15% | +$29.5K | ﹤0.01% | 2062 |
|
|
2021
Q1 | $214K | Buy |
+8,318
| New | +$214K | ﹤0.01% | 2000 |
|